A Standardized Critical Size Defect Model in Normal and Osteoporotic Rats to Evaluate Bone Tissue Engineered Constructs

Figure 2

BMD loss over time (T1: 0 weeks; T2: 5 weeks; T3: 13 weeks) in the ovariectomised groups (groups II) and the nonovariectomised defect group (group I).